Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines, helping make people’s lives easier, fuller and longer.

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat heart disease, obesity and obesity-related conditions, rare diseases, inflammatory conditions and cancer.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

The Rhythm
of Life

Watch Video

Reaching Seriously Ill Patients Worldwide

We have a presence in approximately 100 countries worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. We focus on four therapeutic areas, general medicine, rare disease, inflammation, and oncology, delivering innovative medicines to help make people's lives easier, fuller and longer.

Investing in Science and Innovation

We pursue new ways to do science using tools like AI, generative biology and human data to discover what is not yet known and develop new precision medicines to fight the world’s toughest diseases.

Making Medicines Safely and Reliably

Many of Amgen's medicines are made through a highly complex process involving living cells. We aim to deliver for "every patient, every time", and we have a long-running reputation for the reliability of our supply chain.

Operating Responsibly

Making a positive difference in the world is at the heart of what we do at Amgen — and it goes beyond making vital medicines. We also help build a better world by focusing on environmental, social and governance issues that matter most to our business and our stakeholders.

DOWNLOADS

download-icon

Amgen Fact Sheet

In This Section

Letter to Our Shareholdersicon

Amgen delivered strong results in 2024. We reached millions of patients worldwide with our life-changing medicines, advanced the broadest and deepest pipeline in our history, and positioned ourselves to deliver attractive long-term growth.

Mission and Valuesicon

Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.

    Leadershipicon

    As one of the early pioneers of the biotech industry, Amgen's innovative and inspirational leadership is a core part of our social architecture.

    Therapy Areasicon

    At Amgen, we are committed to delivering innovative medicines in four key therapeutic areas: general medicine, rare diseases, inflammation, and oncology.

      How We Operateicon

      At Amgen, we are relentless in applying the highest ethical standards to everything we do.

      Awards and Accoladesicon

      Amgen has been the recipient of numerous awards and accolades over the years, ranging from recognition of our pioneering science and innovation, philanthropy and corporate social responsibility to our commitment to being a great place to work.

        Amgen Historyicon

        A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies and has reached millions of patients around the world.

          RELATED LINKS

          Stock Information

          press-release-tile-desktoppress-releases-tile-related-links-mobile

          Press Releases

          Amgen Science

          Amgen Business Development